A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cell Host and Microbe

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.chom.2013.06.005PMID 23870318PMCID PMC3780791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine

  2012cited by this paper
• Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.

  2012cited by this paper
• Complete Plasmodium falciparum liver-stage development in liver-chimeric mice.

  2012cited by this paper
• Organotypic liver culture models: Meeting current challenges in toxicity testing

  2012cited by this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2011cited by this paper
• A Research Agenda to Underpin Malaria Eradication

  2011cited by this paper
• A Research Agenda for Malaria Eradication: Drugs

  2011cited by this paper
• Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity

  2011influential reference
• Humanized mice with ectopic artificial liver tissues

  2011cited by this paper
• Establishment of an In Vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria

  2010influential reference
• Plasmodium yoelii-Infected A. stephensi Inefficiently Transmit Malaria Compared to Intravenous Route

  2010cited by this paper
• Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.

  2010cited by this paper
• Thousands of chemical starting points for antimalarial lead identification

  2010cited by this paper
• Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

  2010cited by this paper
• Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

  2010cited by this paper
• Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites

  2010cited by this paper
• General review on in vitro hepatocyte models and their applications.

  2010cited by this paper
• Chemical genetics of Plasmodium falciparum

  2010cited by this paper
• Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures

  2010cited by this paper
• Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events

  2009cited by this paper
• Sterile Protection against Plasmodium knowlesi in Rhesus Monkeys from a Malaria Vaccine: Comparison of Heterologous Prime Boost Strategies

  2009cited by this paper
• The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria.

  2009cited by this paper
• Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection.

  2008cited by this paper
• Kinome-Wide RNAi Screen Implicates at Least 5 Host Hepatocyte Kinases in Plasmodium Sporozoite Infection

  2008cited by this paper
• Microscale culture of human liver cells for drug development

  2008influential reference
• Gene Disruption of Plasmodium falciparum p52 Results in Attenuation of Malaria Liver Stage Development in Cultured Primary Human Hepatocytes

  2008cited by this paper
• Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection.

  2008cited by this paper
• Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection.

  2008cited by this paper
• CellProfiler Analyst: data exploration and analysis software for complex image-based screens

  2008cited by this paper
• Vivax malaria: neglected and not benign.

  2007cited by this paper
• Alternative invasion pathways for Plasmodium berghei sporozoites.

  2007cited by this paper
• Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.

  2007cited by this paper
• Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax.

  2006cited by this paper
• CellProfiler: image analysis software for identifying and quantifying cell phenotypes

  2006cited by this paper
• Genetically modified Plasmodium parasites as a protective experimental malaria vaccine

  2005cited by this paper
• Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells

  2004cited by this paper
• A Role for Apical Membrane Antigen 1 during Invasion of Hepatocytes by Plasmodium falciparum Sporozoites*

  2004cited by this paper
• Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity

  2003cited by this paper
• Case report: An unusual late relapse of Plasmodium vivax malaria.

  2003cited by this paper
• Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii

  2002cited by this paper
• Migration of Plasmodium sporozoites through cells before infection.

  2001cited by this paper
• Effect of cell–cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells

  1999cited by this paper
• Complete development of the liver stage of Plasmodium falciparum in a human hepatoma cell line.

  1995cited by this paper
• The hypnozoite and relapse in primate malaria

  1992cited by this paper
• Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes.

  1989cited by this paper
• Malaria sporozoite penetration. A new approach by double staining.

  1988cited by this paper
• Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee.

  1986cited by this paper
• In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells.

  1986cited by this paper
• Complete development of hepatic stages of Plasmodium falciparum in vitro.

  1985cited by this paper
• Infection of cryopreserved adult human hepatocytes with Plasmodium falciparum sporozoites.

  1985cited by this paper
• Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax.

  1985cited by this paper
• Cultivation of the liver forms of Plasmodium vivax in human hepatocytes

  1984cited by this paper
• In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei in a hepatoma cell line.

  1983cited by this paper
• Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection.

  1982cited by this paper
• Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax

  1982cited by this paper
• A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics.

  1975cited by this paper
• The pre-erythrocytic stage of plasmodium falciparum

  1951cited by this paper
• Pre-erythrocytic Stage of Plasmodium Falciparum

  1949cited by this paper
• The pre-erythrocytic development of Plasmodium cynomolgi and Plasmodium vivax.

  1948cited by this paper

• Genome-wide gene expression profiles throughout human malaria parasite liver stage development in humanized mice

  2025cites this paper
• Heterotypic spheroids as a strategy for 3D culture of cryopreserved primary human hepatocytes in stirred-tank systems.

  2025cites this paper
• Evidence for infectious merozoites of Plasmodium falciparum from natural isolates of cultured hepatoma cells infected with sporozoites

  2025cites this paper
• Leveraging microphysiological systems to expedite understanding of host–parasite interactions

  2025cites this paper
• Recent Trends and Perspectives on Malaria Relapse: A Mini Review.

  2025cites this paper
• Two Plasmodium vivax hypnozoite-expressed RNA-binding proteins inhibit liver stage replication

  2025cites this paper
• Spatial patterning strategies for liver tissue engineering: Biofabrication technologies and applications

  2025cites this paper
• Induced pluripotent stem cell-based tissue models to study malaria: a new player in the research game.

  2025cites this paper
• Experimental models of liver-stage malaria: Progress, gaps, and challenges

  2025cites this paper
• In vitro liver models for toxicological research.

  2025cites this paper
• Cas9-expressing HC-04 hepatocytes facilitate CRISPR-based analysis of Plasmodium falciparum sporozoite-host interactions

  2025cites this paper
• Unraveling the intricacies of host-pathogen interaction through single-cell genomics.

  2024cites this paper
• A candidate antibody drug for prevention of malaria

  2024cites this paper
• Autonomous circadian rhythms in the human hepatocyte regulate hepatic drug metabolism and inflammatory responses

  2024cites this paper
• A 3D organoid platform that supports liver-stage P.falciparum infection can be used to identify intrahepatic antimalarial drugs

  2024cites this paper
• Human liver organoids are susceptible to Plasmodium vivax infection

  2024cites this paper
• Transfection Models to Investigate Plasmodium vivax-Type Dormant Liver Stage Parasites

  2023cites this paper
• Emergence of In Vitro 3D Systems to Model Human Malaria

  2023influential citation
• Decellularized Liver Nanofibers Enhance and Stabilize the Long‐Term Functions of Primary Human Hepatocytes In Vitro

  2023cites this paper
• 3D-QSAR-based design, synthesis and biological evaluation of 2,4-disubstituted quinoline derivatives as antimalarial agents

  2023cites this paper
• Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum

  2023cites this paper
• Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults

  2023cites this paper
• Comparative analyses of functional antibody-mediated inhibition with anti-circumsporozoite monoclonal antibodies against transgenic Plasmodium berghei

  2023cites this paper
• Global gene expression of human malaria parasite liver stages throughout intrahepatocytic development

  2023cites this paper
• Developing Liver Microphysiological Systems for Biomedical Applications

  2023cites this paper
• Assessment of the drugability of initial malaria infection through miniaturized sporozoite assays and high-throughput screening

  2023cites this paper
• Moving on: How malaria parasites exit the liver

  2023cites this paper
• Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives

  2022cites this paper
• In vitro models for human malaria: targeting the liver stage.

  2022cites this paper
• Recent Advances in Host-Directed Therapies for Tuberculosis and Malaria

  2022cites this paper
• Hemisynthetic derivatives of the natural alkaloid trilobine are fast-acting antimalarial compounds with sustained activity in multi-drug resistant P. falciparum isolates

  2022cites this paper
• Preliminary Assessment of Intramuscular Depot of Lipid-Based Decoquinate Formulation for Long-Term Chemoprophylaxis of Malaria

  2022cites this paper
• Maria M. Mota: Bringing Plasmodium Liver Infection to the Centre Stage of Malaria Research

  2022cites this paper
• Advancing Key Gaps in the Knowledge of Plasmodium vivax Cryptic Infections Using Humanized Mouse Models and Organs-on-Chips

  2022cites this paper
• Development of an ectopic huLiver model for Plasmodium liver stage infection

  2022cites this paper
• Co-culture of liver parenchymal cells with non-parenchymal cells under 2D and 3D culture systems; a review paper.

  2022cites this paper
• A vascularized model of the human liver mimics regenerative responses

  2022cites this paper
• Transcending Dimensions in Apicomplexan Research: from Two-Dimensional to Three-Dimensional In Vitro Cultures

  2022cites this paper
• Physiomimetic In Vitro Human Models for Viral Infection in the Liver

  2022cites this paper
• A Phenotypic Screen for the Liver Stages of Plasmodium vivax.

  2021cites this paper
• Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite.

  2021cites this paper
• A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites

  2021cites this paper
• Latest impact of engineered human liver platforms on drug development

  2021cites this paper
• iPSCs for modeling hepatotropic pathogen infections

  2021cites this paper
• Emerging liver organoid platforms and technologies

  2021cites this paper
• Next-Generation Human Liver Models for Antimalarial Drug Assays

  2021influential citation
• Dissection-independent production of Plasmodium sporozoites from whole mosquitoes

  2021cites this paper
• Plasmodium falciparum infected humanized mice: a viable preclinical tool.

  2021cites this paper
• Plasmodium vivax Latent Liver Stage Infection and Relapse: Biological Insights and New Experimental Tools.

  2021cites this paper
• Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine

  2021cites this paper
• Modeling Relapsing Malaria: Emerging Technologies to Study Parasite-Host Interactions in the Liver

  2021cites this paper
• Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity

  2021cites this paper
• Characterization of the Tubovesicular Network in Plasmodium vivax Liver Stage Hypnozoites and Schizonts

  2021cites this paper
• Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens

  2020cites this paper
• The Hepatocyte as a Household for Plasmodium Parasites

  2020cites this paper
• Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria

  2020cites this paper
• Analysis of Host Responses to Hepatitis B and Delta Viral Infections in a Micro‐scalable Hepatic Co‐culture System

  2020cites this paper
• A Novel Chemically Differentiated Mouse Embryonic Stem Cell-Based Model to Study Liver Stages of Plasmodium berghei

  2020cites this paper
• An adaptable soft-mold embossing process for fabricating optically-accessible, microfeature-based culture systems and application toward liver stage antimalarial compound testing.

  2020cites this paper
• Dissection-independent production of a protective whole-sporozoite malaria vaccine

  2020cites this paper
• Hypnozoites in Plasmodium: Do Parasites Parallel Plants?

  2020cites this paper
• The tubovesicular network in Plasmodium vivax liver-stage hypnozoites and schizonts associates with host aquaporin 3

  2020cites this paper
• Plasmodium vivax liver stage assay platforms using Indian clinical isolates

  2020cites this paper
• Targeting liver stage malaria with metformin.

  2019cites this paper
• Organoids for Liver Stage Malaria Research.

  2019cites this paper
• Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development.

  2019cites this paper
• Antimalarial activity of primaquine operates via a two-step biochemical relay

  2019cites this paper
• Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers

  2019cites this paper
• Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data

  2019cites this paper
• Genetic affinities of an eradicated European Plasmodium falciparum strain

  2019cites this paper
• Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages

  2019cites this paper
• Developing Plasmodium cynomolgi culture as a model to investigate antimalarial effects on Plasmodium vivax

  2019influential citation
• The antimalarial screening landscape—looking beyond the asexual blood stage

  2019cites this paper
• Cell Culture Models for Hepatitis E Virus

  2019cites this paper
• The Selection of a Hepatocyte Cell Line Susceptible to Plasmodium falciparum Sporozoite Invasion That Is Associated With Expression of Glypican-3

  2019cites this paper
• Flexible 3D cell-based platforms for the discovery and profiling of novel drugs targeting Plasmodium hepatic infection.

  2019cites this paper
• Steroid Hormone Function Controls Non-competitive Plasmodium Development in Anopheles.

  2019cites this paper
• 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications

  2019cites this paper
• The Plasmodium liver-specific protein 2 (LISP2) is an early marker of liver stage development

  2019cites this paper
• Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection.

  2019cites this paper
• An Immortalized Hepatocyte-Like Cell Line (imHC) Accommodated Complete Viral Lifecycle, Viral Persistence Form, cccDNA and Eventual Spreading of a Clinically-Isolated HBV

  2019cites this paper
• Hepatic spheroids used as an in vitro model to study malaria relapse.

  2019cites this paper
• Developing Plasmodium vivax Resources for Liver Stage Study in the Peruvian Amazon Region.

  2018cites this paper
• Hepatitis E virus: advances and challenges

  2018cites this paper
• A human monoclonal antibody prevents malaria infection and defines a new site of vulnerability on Plasmodium falciparum circumsporozoite protein

  2018cites this paper
• A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum

  2018cites this paper
• A Plasmodium berghei sporozoite-based vaccination platform against human malaria

  2018cites this paper
• Advances in Engineered Human Liver Platforms for Drug Metabolism Studies

  2018cites this paper
• Engineered Human Liver Cocultures for Investigating Drug-Induced Liver Injury

  2018cites this paper
• Opportunities for Host-targeted Therapies for Malaria.

  2018cites this paper
• Current Screening Methodologies in Drug Discovery for Selected Human Diseases

  2018cites this paper
• Modeling Liver Diseases Using Hepatic Cell Microarrays

  2018cites this paper
• Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia

  2018cites this paper
• Assessing drug efficacy against Plasmodium falciparum liver stages in vivo.

  2018cites this paper
• Continuous Supply of Plasmodium vivax Sporozoites from Colonized Anopheles darlingi in the Peruvian Amazon

  2018cites this paper
• Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.

  2018cites this paper
• A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax

  2018cites this paper
• Deposited in DRO : 11 January 2018 Version of attached

  2018cites this paper
• Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding.

  2018cites this paper
• A human monoclonal antibody prevents malaria infection and defines a new site of vulnerability on Plasmodium falciparum circumsporozoite protein

  2018cites this paper